167 related articles for article (PubMed ID: 35068191)
1. Estradiol and RSPO3 regulate vertebral trabecular bone mass independent of each other.
Nilsson KH; Wu J; Gustafsson KL; El Shahawy M; Koskela A; Tuukkanen J; Tuckermann J; Henning P; Lerner UH; Ohlsson C; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E211-E218. PubMed ID: 35068191
[TBL] [Abstract][Full Text] [Related]
2. RSPO3 is important for trabecular bone and fracture risk in mice and humans.
Nilsson KH; Henning P; El Shahawy M; Nethander M; Andersen TL; Ejersted C; Wu J; Gustafsson KL; Koskela A; Tuukkanen J; Souza PPC; Tuckermann J; Lorentzon M; Ruud LE; Lehtimäki T; Tobias JH; Zhou S; Lerner UH; Richards JB; Movérare-Skrtic S; Ohlsson C
Nat Commun; 2021 Aug; 12(1):4923. PubMed ID: 34389713
[TBL] [Abstract][Full Text] [Related]
3. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
[TBL] [Abstract][Full Text] [Related]
4. The bone-sparing effects of estrogen and WNT16 are independent of each other.
Movérare-Skrtic S; Wu J; Henning P; Gustafsson KL; Sjögren K; Windahl SH; Koskela A; Tuukkanen J; Börjesson AE; Lagerquist MK; Lerner UH; Zhang FP; Gustafsson JÅ; Poutanen M; Ohlsson C
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14972-7. PubMed ID: 26627248
[TBL] [Abstract][Full Text] [Related]
5. 17α-Estradiol prevents ovariectomy-mediated obesity and bone loss.
Mann SN; Pitel KS; Nelson-Holte MH; Iwaniec UT; Turner RT; Sathiaseelan R; Kirkland JL; Schneider A; Morris KT; Malayannan S; Hawse JR; Stout MB
Exp Gerontol; 2020 Dec; 142():111113. PubMed ID: 33065227
[TBL] [Abstract][Full Text] [Related]
6. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
[TBL] [Abstract][Full Text] [Related]
7. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
[TBL] [Abstract][Full Text] [Related]
8. Roles of transactivating functions 1 and 2 of estrogen receptor-alpha in bone.
Börjesson AE; Windahl SH; Lagerquist MK; Engdahl C; Frenkel B; Movérare-Skrtic S; Sjögren K; Kindblom JM; Stubelius A; Islander U; Antal MC; Krust A; Chambon P; Ohlsson C
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6288-93. PubMed ID: 21444817
[TBL] [Abstract][Full Text] [Related]
9. The effects of estradiol are modulated in a tissue-specific manner in mice with inducible inactivation of ERα after sexual maturation.
Ohlsson C; Farman HH; Gustafsson KL; Wu J; Henning P; Windahl SH; Sjögren K; Gustafsson JÅ; Movérare-Skrtic S; Lagerquist MK
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E646-E654. PubMed ID: 32125882
[TBL] [Abstract][Full Text] [Related]
10. SERMs have substance-specific effects on bone, and these effects are mediated via ERαAF-1 in female mice.
Börjesson AE; Farman HH; Movérare-Skrtic S; Engdahl C; Antal MC; Koskela A; Tuukkanen J; Carlsten H; Krust A; Chambon P; Sjögren K; Lagerquist MK; Windahl SH; Ohlsson C
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E912-8. PubMed ID: 27048997
[TBL] [Abstract][Full Text] [Related]
11. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
12. The effect of estrogen on bone requires ERα in nonhematopoietic cells but is enhanced by ERα in hematopoietic cells.
Henning P; Ohlsson C; Engdahl C; Farman H; Windahl SH; Carlsten H; Lagerquist MK
Am J Physiol Endocrinol Metab; 2014 Oct; 307(7):E589-95. PubMed ID: 25117411
[TBL] [Abstract][Full Text] [Related]
13. Ovariectomy-induced bone loss varies among inbred strains of mice.
Bouxsein ML; Myers KS; Shultz KL; Donahue LR; Rosen CJ; Beamer WG
J Bone Miner Res; 2005 Jul; 20(7):1085-92. PubMed ID: 15940361
[TBL] [Abstract][Full Text] [Related]
14. Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice.
Lei T; Liang Z; Li F; Tang C; Xie K; Wang P; Dong X; Shan S; Jiang M; Xu Q; Luo E; Shen G
Bone; 2018 Mar; 108():10-19. PubMed ID: 29229438
[TBL] [Abstract][Full Text] [Related]
15. Osteoblast-derived NOTUM reduces cortical bone mass in mice and the
Movérare-Skrtic S; Nilsson KH; Henning P; Funck-Brentano T; Nethander M; Rivadeneira F; Coletto Nunes G; Koskela A; Tuukkanen J; Tuckermann J; Perret C; Souza PPC; Lerner UH; Ohlsson C
FASEB J; 2019 Oct; 33(10):11163-11179. PubMed ID: 31307226
[TBL] [Abstract][Full Text] [Related]
16. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.
Wu RW; Lian WS; Chen YS; Ko JY; Wang SY; Jahr H; Wang FS
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502380
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
[TBL] [Abstract][Full Text] [Related]
18. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
Wang ML; Massie J; Perry A; Garfin SR; Kim CW
Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D modulation of the activity of estrogenic compounds in bone cells in vitro and in vivo.
Somjen D
Crit Rev Eukaryot Gene Expr; 2007; 17(2):115-47. PubMed ID: 17725484
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of substance P signaling aggravates the bone loss in ovariectomy-induced osteoporosis.
Zheng XF; Zhao ED; He JY; Zhang YH; Jiang SD; Jiang LS
Prog Biophys Mol Biol; 2016 Nov; 122(2):112-121. PubMed ID: 27237582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
